Embleema

Patients can:

• Register and sign-on through the Patient Dapp interface,

• Upload their health records in the Blockchain, • Visualize their patient record,

• Authorize the sharing of their identified patient record to providers,

• Expose and sell their health records in the Marketplace against RWE tokens,

• Visualize a full audit-trail on their patient record access and health records sold,

• Visualize a statement of his/her RWE transactions.

Providers can:

• Register and sign-on through the Provider Dapp interface,

• Visualize an identified patient record, with due consent from the patient,

• Perform a health record quality check, when requested by the health record data owner,

• Visualize a statement of his/her RWE transactions,

Care Centers and other Data Owners can:

• Register and sign-on through the Data Owner Dapp interface,

• Have their health records indexed into the Blockchain and linked to patients,

• Expose and sell their health records in the Marketplace against RWE tokens, with due consent from the patients,

• Visualize a statement of RWE transactions,

Pharma companies, Payers and other Data Buyers can:

• Register and sign-on through the Data Buyer Dapp interface,

• Expose their inclusion criteria for health record purchases,

• Browse a list of data owners which own health records matching their inclusion criteria,

• Select the data owners they wish to purchase health records from,

• Execute the purchase in RWE tokens with data owners,

• Visualize a statement of RWE transactions,

Pharma companies and authorities can:

• Register and sign-on through the Real-World Evidence Dapp interface,

• Pharma companies register health products on which they wish to share with authorities Real-World Evidence, and define the patient records they wish to share,

• Authorities can visualize the shared Real-World Evidence from Pharma companies.

We expect Version 2 to be HIPAA compliant (see “Embleema and Privacy Compliance section” below) for the U.S. users and GDPR compliant for the European users. Version 2 will include health records from U.S. patients. Version 2 is planned to launch in Q3 2019.